A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share comparison images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Worries
However, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting products of unknown origin.
Several experts said the popularity for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, legal action or imprisonment.
Service Response and Material Elimination
According to TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the service secure and investing in strengthening compliance measures.
Online Marketplace Activities
Research also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.
After minutes of entering one group, a seller posted contact information, where the majority of purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.
Product Information and Pricing
Inside these communities, posts show black plastic packages with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has already encountered individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially significant health risks”.
